<h3>Objective:</h3> We will share our experience establishing a neurology department Diversity, Equity, and Inclusion (DEI) committee broadly inclusive of faculty, housestaff, physician assistants (PAs), and administrative staff. <h3>Background:</h3> Responding to feedback for a need to promote healthcare equity, we brought together an integrated neurology department team to develop a shared vision toward advancing DEI across academic, research, and clinical programs. <h3>Design/Methods:</h3> This interdisciplinary DEI committee is comprised of faculty, housestaff, PAs, and administrative staff volunteers. This includes junior and senior faculty, a neuropsychologist, each post-graduate year level, and one fellow. We created a mission statement, developed short- and long-term goals, provided events including stakeholder studios to understand the needs/values of the department and community, all towards developing a roadmap to improve DEI. <h3>Results:</h3> Recognizing the importance of the DEI mission, a chair position with protected time was created for selection by the committee for appointment. Complimented by a yearly housestaff DEI Chair. Efforts were advanced through monthly meetings including: implementing a health disparities grand rounds series; additional DEI-related seminars to the housestaff curriculum and faculty professional development, including participation in the AAN anti-racism pilot. To understand “what matters”, we engaged in local community programs to integrate constructive feedback on barriers to neurologic care and facilitators to health equity. Promoting research efforts, our members have contributed to >10 publications across DEI-related and health equity areas. <h3>Conclusions:</h3> Embracing DEI within a neurology department is crucial for community-centered comprehensive neurologic care and cultivating a thriving training environment. Forming a neurology DEI committee created an organizational framework now embedded into the culture. We combined leadership, education, and advocacy initiatives to promote inclusivity and work towards a future of DEI throughout neurology. We hope these efforts will motivate neurology departments to establish a DEI committee to both bring awareness and promote equity within their community at large. <b>Disclosure:</b> Dr. Abiola has nothing to disclose. Dr. Lendaris has nothing to disclose. Dr. Wallace has nothing to disclose. Dr. Armand has received personal compensation in the range of $0-$499 for serving as a Consultant for Abbvie. Dr. Armand has received personal compensation in the range of $500-$4,999 for serving as a Consultant for TEVA. Dr. Armand has received personal compensation in the range of $5,000-$9,999 for serving as a Consultant for Spire Learning. Dr. Armand has received personal compensation in the range of $500-$4,999 for serving as an Editor, Associate Editor, or Editorial Advisory Board Member for JAMA Neurology. Ms. Bartolomeo has nothing to disclose. Dr. Drakou has nothing to disclose. Dr. Esenwa has nothing to disclose. Mrs. Fofana has nothing to disclose. Dr. Gursky has nothing to disclose. Dr. Hunter has nothing to disclose. Dr. Napier has nothing to disclose. Dr. Pavlovic has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Biohaven. Ms. Poole has nothing to disclose. Dr. Thongsing has nothing to disclose. Mrs. Vlasaty has nothing to disclose. Dr. Zwerling has nothing to disclose. The institution of Erica Weiss has received research support from NIH. The institution of Erica Weiss has received research support from NY State Dept of Health. Dr. Correa has received personal compensation in the range of $0-$499 for serving as a Consultant for Independent Medical Consultants. Dr. Correa has received personal compensation in the range of $0-$499 for serving as a Consultant for Atheneum Partners. Dr. Correa has received personal compensation in the range of $10,000-$49,999 for serving as an Editor, Associate Editor, or Editorial Advisory Board Member for American Academy of Neurology. Dr. Correa has stock in Aidin Inc. Dr. Correa has received research support from Genentech. Dr. Correa has received research support from Psi Upsilon Foundation Inc.